- Home
- ABVC vs SACH Comparison
ABVC vs SACH Comparison
Compare ABVC & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- SACH
- Stock Information
- Founded
- ABVC 2015
- SACH 2010
- Country
- ABVC United States
- SACH United States
- Employees
- ABVC N/A
- SACH N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- SACH Real Estate Investment Trusts
- Sector
- ABVC Health Care
- SACH Real Estate
- Exchange
- ABVC Nasdaq
- SACH Nasdaq
- Market Cap
- ABVC 52.1M
- SACH 54.4M
- IPO Year
- ABVC N/A
- SACH 2017
- Fundamental
- Price
- ABVC $2.72
- SACH $1.33
- Analyst Decision
- ABVC
- SACH Hold
- Analyst Count
- ABVC 0
- SACH 4
- Target Price
- ABVC N/A
- SACH $2.25
- AVG Volume (30 Days)
- ABVC 117.4K
- SACH 210.4K
- Earning Date
- ABVC 08-13-2025
- SACH 08-05-2025
- Dividend Yield
- ABVC N/A
- SACH 15.63%
- EPS Growth
- ABVC N/A
- SACH N/A
- EPS
- ABVC N/A
- SACH N/A
- Revenue
- ABVC $391,242.00
- SACH N/A
- Revenue This Year
- ABVC $735.18
- SACH N/A
- Revenue Next Year
- ABVC N/A
- SACH $7.74
- P/E Ratio
- ABVC N/A
- SACH N/A
- Revenue Growth
- ABVC 186.84
- SACH N/A
- 52 Week Low
- ABVC $0.40
- SACH $0.80
- 52 Week High
- ABVC $5.48
- SACH $2.70
- Technical
- Relative Strength Index (RSI)
- ABVC 45.17
- SACH 67.64
- Support Level
- ABVC $2.51
- SACH $1.20
- Resistance Level
- ABVC $3.14
- SACH $1.27
- Average True Range (ATR)
- ABVC 0.21
- SACH 0.05
- MACD
- ABVC -0.04
- SACH 0.01
- Stochastic Oscillator
- ABVC 24.85
- SACH 90.49
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.